Lobbying

Mainstay Medical's latest lobbying report covers Q4 2024, at $20K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.

Mainstay Medical

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Mainstay Medical lobbying by quarter
Mainstay Medical lobbying by quarter
QuarterAmountReports
Q4 2022$30K1
Q1 2023$30K1
Q2 2023$30K1
Q3 2023$50K1
Q4 2023$50K1
Q1 2024$20K2
Q2 2024$20K2
Q3 2024$30K1
Q4 2024$20K1
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$155K · 9 reports
  • Medicare and Medicaid$125K · 8 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES5 reports
  • SENATE5 reports
  • Centers For Medicare and Medicaid Services (CMS)3 reports

Firms it paid

Firm
Akin Gump Strauss Hauer & Feld$190K7 quarters
Manatt, Phelps, and Phillips$90K4 quarters

Former officials lobbying for it

Former position
EDWARD ABRY WATERSLegislative Assistant to Rep. Timothy Bishop (NY-01)Q4 2024
HEIDE BAJNRAUHSenator McCain Intern 94-96;LSA96-97Q2 2024

Lobbying reports

Filed by
25/01/15for Q4 2024Manatt, Phelps, and Phillips$20K
24/10/23for Q3 2024Manatt, Phelps, and Phillips$30K
24/10/06for Q3 2024Manatt, Phelps, and Phillips$30K
24/10/06for Q3 2024Manatt, Phelps, and Phillips$30K
24/07/19for Q2 2024Akin Gump Strauss Hauer & FeldUnder $5,000
24/07/11for Q2 2024Manatt, Phelps, and Phillips$20K
24/06/13for Q1 2024Manatt, Phelps, and Phillips$20K
24/06/12for Q1 2024Manatt, Phelps, and Phillips$20K
24/06/12for Q1 2024Manatt, Phelps, and Phillips$15K
24/05/21for Q1 2024Manatt, Phelps, and PhillipsUnder $5,000
24/04/19for Q1 2024Akin Gump Strauss Hauer & FeldUnder $5,000
24/01/19for Q4 2023Akin Gump Strauss Hauer & Feld$50K
23/10/20for Q3 2023Akin Gump Strauss Hauer & Feld$50K
23/07/20for Q2 2023Akin Gump Strauss Hauer & Feld$30K
23/07/20for Q2 2023Akin Gump Strauss Hauer & Feld$30K
23/04/20for Q1 2023Akin Gump Strauss Hauer & Feld$30K
23/01/20for Q4 2022Akin Gump Strauss Hauer & Feld$30K